Equisights Research (“Equisights”) is a distinguished independent sell-side research firm that excels in delivering in-depth, objective analysis and strategic insights. Our research efforts are primarily centered on the U.S. markets, with a strong sectoral emphasis on Technology, Media, and Telecommunications (TMT), healthcare, consumer cyclicals & non-cyclicals, industrials, energy, and select financials. Equisights serves to several notable buy-side funds, RIAs, family offices, and over 1,000 institutional relationships, who take positions across our coverage universe and manage portfolios ranging from $100 million to $1 billion in assets.
Our comprehensive research framework involves an in-depth analysis of each company’s growth potential, financial health, management quality, industry position, risk factors, and valuation. Our recommendations and ratings process is based on gathering and interpreting data, drawing conclusions, and evaluating these factors to determine final ratings based on intrinsic value, expected growth, and risks. Equisights maintains its independence by not participating in public offerings, advising on mergers and acquisitions, brokering trades, making markets in stocks, or managing money.
RESEARCH FEED : OUR PERSPECTIVE
- Levi Strauss beats quarterly expectations, raises guidance and dividend
- Samsung posts 1,800% jump in profit, but AI spending concerns spook investors
- After a soft Nike quarter, we have a big decision to make on the stock
- Nike is set to report earnings after the bell. Here's what to expect
- AeroVironment skyrockets 21% as dronemaker capitalizes on defense spending surge
- AeroVironment soars 17% on earnings beat, backlog grows to $1.2 billion
- Michael Burry bets on sportsbooks DraftKings and Flutter, sees prediction markets curbed by regulation
- Fed officials were split on direction of interest rates at last meeting, minutes show
- Strait of Hormuz traffic won't return to normal until 2027 after latest setback, Kalshi traders predict
- Stocks making the biggest moves premarket: United Airlines, Micron, Chevron & more
- Fed meeting minutes to show 'family fight' over rates. The squabble could drag on for a while
- China warns about AI risks with Anthropic's Claude Code
- Device maker Stryker strikes $4.9 billion deal for Inari Medical
- Despite revamped proposals, Nippon Steel deal on track to be blocked, letter shows
- Rosneft, Reliance agree biggest ever India-Russia oil supply deal
- Worldline attracts early stage interest from private equity firms
- India’s Andhra Pradesh state likely to suspend Adani power deal
- Sony is in talks to buy media powerhouse behind ‘Elden Ring’

